131 related articles for article (PubMed ID: 22152341)
1. Eyes open to stem cells: safety trial may pave the way for cell therapy to treat retinal disease in patients.
Medina RJ; Archer DB; Stitt AW
Stem Cell Res Ther; 2011 Dec; 2(6):47. PubMed ID: 22152341
[TBL] [Abstract][Full Text] [Related]
2. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies.
Schwartz SD; Regillo CD; Lam BL; Eliott D; Rosenfeld PJ; Gregori NZ; Hubschman JP; Davis JL; Heilwell G; Spirn M; Maguire J; Gay R; Bateman J; Ostrick RM; Morris D; Vincent M; Anglade E; Del Priore LV; Lanza R
Lancet; 2015 Feb; 385(9967):509-16. PubMed ID: 25458728
[TBL] [Abstract][Full Text] [Related]
3. Embryonic stem cell implantation for the treatment of Stargardt’s disease and macular degeneration.
Regen Med; 2011 Sep; 6(5):539-40. PubMed ID: 21916588
[No Abstract] [Full Text] [Related]
4. Embryonic stem cell trials for macular degeneration: a preliminary report.
Schwartz SD; Hubschman JP; Heilwell G; Franco-Cardenas V; Pan CK; Ostrick RM; Mickunas E; Gay R; Klimanskaya I; Lanza R
Lancet; 2012 Feb; 379(9817):713-20. PubMed ID: 22281388
[TBL] [Abstract][Full Text] [Related]
5. Cell-based therapies for retinal diseases: a review of clinical trials and direct to consumer "cell therapy" clinics.
Hinkle JW; Mahmoudzadeh R; Kuriyan AE
Stem Cell Res Ther; 2021 Oct; 12(1):538. PubMed ID: 34635174
[TBL] [Abstract][Full Text] [Related]
6. Stem cells in age-related macular degeneration and Stargardt's macular dystrophy.
Sunness JS
Lancet; 2015 Jul; 386(9988):29. PubMed ID: 26169864
[No Abstract] [Full Text] [Related]
7. Stem cells in age-related macular degeneration and Stargardt's macular dystrophy.
Zhang GY; Liao T; Fu XB; Li QF
Lancet; 2015 Jul; 386(9988):29-30. PubMed ID: 26169863
[No Abstract] [Full Text] [Related]
8. Stem cells in age-related macular degeneration and Stargardt's macular dystrophy - Authors' reply.
Schwartz SD; Anglade E; Lanza R;
Lancet; 2015 Jul; 386(9988):30. PubMed ID: 26169867
[No Abstract] [Full Text] [Related]
9. Stem cells in retinal regeneration: past, present and future.
Ramsden CM; Powner MB; Carr AJ; Smart MJ; da Cruz L; Coffey PJ
Development; 2013 Jun; 140(12):2576-85. PubMed ID: 23715550
[TBL] [Abstract][Full Text] [Related]
10. Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration.
Lu B; Malcuit C; Wang S; Girman S; Francis P; Lemieux L; Lanza R; Lund R
Stem Cells; 2009 Sep; 27(9):2126-35. PubMed ID: 19521979
[TBL] [Abstract][Full Text] [Related]
11. Ocular Stem Cell Research from Basic Science to Clinical Application: A Report from Zhongshan Ophthalmic Center Ocular Stem Cell Symposium.
Ouyang H; Goldberg JL; Chen S; Li W; Xu GT; Li W; Zhang K; Nussenblatt RB; Liu Y; Xie T; Chan CC; Zack DJ
Int J Mol Sci; 2016 Mar; 17(3):415. PubMed ID: 27102165
[TBL] [Abstract][Full Text] [Related]
12. Pluripotent human stem cells for the treatment of retinal disease.
Rowland TJ; Buchholz DE; Clegg DO
J Cell Physiol; 2012 Feb; 227(2):457-66. PubMed ID: 21520078
[TBL] [Abstract][Full Text] [Related]
13. Increased cone sensitivity to ABCA4 deficiency provides insight into macular vision loss in Stargardt's dystrophy.
Conley SM; Cai X; Makkia R; Wu Y; Sparrow JR; Naash MI
Biochim Biophys Acta; 2012 Jul; 1822(7):1169-79. PubMed ID: 22033104
[TBL] [Abstract][Full Text] [Related]
14. Stem Cell Transplantation Therapy for Retinal Degenerative Diseases.
Han F; Xu G
Adv Exp Med Biol; 2020; 1266():127-139. PubMed ID: 33105499
[TBL] [Abstract][Full Text] [Related]
15. Stem cell based therapies for age-related macular degeneration: The promises and the challenges.
Nazari H; Zhang L; Zhu D; Chader GJ; Falabella P; Stefanini F; Rowland T; Clegg DO; Kashani AH; Hinton DR; Humayun MS
Prog Retin Eye Res; 2015 Sep; 48():1-39. PubMed ID: 26113213
[TBL] [Abstract][Full Text] [Related]
16. Cell-Based Therapy for Degenerative Retinal Disease.
Zarbin M
Trends Mol Med; 2016 Feb; 22(2):115-134. PubMed ID: 26791247
[TBL] [Abstract][Full Text] [Related]
17. Long-term safety and tolerability of subretinal transplantation of embryonic stem cell-derived retinal pigment epithelium in Asian Stargardt disease patients.
Sung Y; Lee MJ; Choi J; Jung SY; Chong SY; Sung JH; Shim SH; Song WK
Br J Ophthalmol; 2021 Jun; 105(6):829-837. PubMed ID: 32727729
[TBL] [Abstract][Full Text] [Related]
18. Targeting the cAMP and Transforming Growth Factor-β Pathway Increases Proliferation to Promote Re-Epithelialization of Human Stem Cell-Derived Retinal Pigment Epithelium.
Choudhary P; Gutteridge A; Impey E; Storer RI; Owen RM; Whiting PJ; Bictash M; Benn CL
Stem Cells Transl Med; 2016 Jul; 5(7):925-37. PubMed ID: 27112176
[TBL] [Abstract][Full Text] [Related]
19. Progressing a human embryonic stem-cell-based regenerative medicine therapy towards the clinic.
Whiting P; Kerby J; Coffey P; da Cruz L; McKernan R
Philos Trans R Soc Lond B Biol Sci; 2015 Oct; 370(1680):20140375. PubMed ID: 26416684
[TBL] [Abstract][Full Text] [Related]
20. Polarized human embryonic stem cell-derived retinal pigment epithelial cell monolayers have higher resistance to oxidative stress-induced cell death than nonpolarized cultures.
Hsiung J; Zhu D; Hinton DR
Stem Cells Transl Med; 2015 Jan; 4(1):10-20. PubMed ID: 25411476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
